Baird Medical Accelerates AI Surgical Software Registration in US, EU and China
Baird Medical has finished development of its AI-driven cross-platform surgical software and initiated registration in the US, EU and China. The system automates anatomical mapping, treatment planning and procedural simulations and integrates with its upcoming fully automated surgical robotic system to accelerate its commercial roadmap.
1. Software Development and Registration
Baird Medical has completed development of its AI-driven cross-platform surgical software and commenced registration processes in the US, EU and China. This milestone initiates regulatory reviews under US FDA, CE marking and China NMPA frameworks, paving the way for market entry in key regions.
2. AI Capabilities and Workflow Automation
The proprietary AI model automates core clinical workflows including anatomical mapping, dynamic treatment planning and procedural simulations by integrating diverse diagnostic imaging data. These features aim to assist physicians in defining precise surgical pathways and parameters for minimally invasive modalities.
3. Robotic Integration and Commercial Strategy
The software is engineered to integrate seamlessly with Baird Medical’s upcoming fully automated surgical robotic system, establishing a closed-loop ecosystem from pre-operative analysis through post-operative evaluation. This end-to-end integration is designed to accelerate the company’s commercial roadmap and meet rising global demand for intelligent interventional solutions.